Dr Joel Lasschuit (BMedSc, MBBS Hons, FRACP, PhD) is an Endocrinologist and clinical researcher who is determined to improve outcomes for people with diabetes-related foot complications. He is a Staff Specialist in the Department of Endocrinology at St Vincent’s Hospital Sydney where he co-leads the High Risk Foot Service (HRFS), accredited by the National Association of Diabetes Centres (NADC) as a Centre of Excellence. Joel undertook his PhD at the Garvan Institute of Medical Research and University of New South Wales, where he now holds appointments as a Visiting Scientist and Conjoint Senior Lecturer, respectively. He coordinated Australia’s first randomised controlled trial for people with acute Charcot foot, investigating use of a novel therapeutic across nine public teaching hospitals. He has presented his research at national and international meetings. As the ADS/NADC HRFS Database Manager he is overseeing implementation of a standardised national registry, attracting participation of over fifty services. He is also involved in NADC HRFS Accreditation. On invitation from Diabetes Feet Australia he co-authored the Australian guidelines on prevention of foot ulceration and has contributed to the upcoming National Strategy for diabetes-related foot disease. Joel co-founded and convenes the Sydney Diabetic Foot Interest Group (SyD FIG),
which brings together clinicians from a breadth of institutions and disciplines nationally to discuss complex cases.